Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment
Abstract Background Financial toxicity from cancer treatments is rising as an important patient-reported outcome. Its relevance was first assessed in the context of privately financed healthcare system, where the financial hardship caused by out-of-pocket payments negatively affects survival, while...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-13230-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850190412397936640 |
|---|---|
| author | Davide Smussi Carlo Conti Luigi Lorini Davide Mattavelli Rosella Levaggi Raffaele Miniaci Stefano Calza Alberto Deganello Consiglia Paduano Andrea Alberti Salvatore Grisanti Carla Ida Ripamonti Alfredo Berruti Cesare Piazza Paolo Bossi |
| author_facet | Davide Smussi Carlo Conti Luigi Lorini Davide Mattavelli Rosella Levaggi Raffaele Miniaci Stefano Calza Alberto Deganello Consiglia Paduano Andrea Alberti Salvatore Grisanti Carla Ida Ripamonti Alfredo Berruti Cesare Piazza Paolo Bossi |
| author_sort | Davide Smussi |
| collection | DOAJ |
| description | Abstract Background Financial toxicity from cancer treatments is rising as an important patient-reported outcome. Its relevance was first assessed in the context of privately financed healthcare system, where the financial hardship caused by out-of-pocket payments negatively affects survival, while fewer evidence exists on its role in countries where care is financed by the public health care system. Head and Neck Cancer (HNC) patients face an increased risk for financial toxicity due to multimodal treatment and relevant out of pocket costs. The aim of this study was to develop and validate an Italian version of the Canadian Financial Index of Toxicity (FIT) questionnaire, defined FITALY. Methods FIT questionnaire was translated through a forward-backward process by two investigators independently, and the process was reviewed by a certified medical scientific English native speaker. Once reached consensus upon Italian translation, two Health Economics experts were consulted to adapt the questionnaire to Italian socio-economic context. The FITALY questionnaire v1.0 hereby developed was anonymously administered to two consecutive groups of 30 patients who had received curative, multimodal treatment for HNC cancer at ASST Spedali Civili of Brescia, Italy. A cognitive debriefing form was simultaneously administered to ask patients to exclude recurring and redundant items and include new relevant items. Results The 14-item FITALY questionnaire provides a global evaluation of financial toxicity ranging from 0 to 100. The questionnaire is divided into 4 domains: financial burden (6 items), exploring the objective financial toxicity burden; financial distress (2 items), which refers to the psychological distress related to financial toxicity; out-of-pocket costs (4 items), which focus on medical expenses paid by the patient; and loss of productivity (2 items), that investigates the disease impact on both patient’s and caregiver’s job activity. Conclusions Starting from the Canadian 9-item FIT questionnaire, we developed and validated the Italian 14-item FITALY questionnaire. Prospective application to a cohort of Italian HNC patients is ongoing. |
| format | Article |
| id | doaj-art-71ca9107fb2e4fc7afc3a1a4303966f8 |
| institution | OA Journals |
| issn | 1471-2407 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj-art-71ca9107fb2e4fc7afc3a1a4303966f82025-08-20T02:15:17ZengBMCBMC Cancer1471-24072025-02-012511810.1186/s12885-024-13230-5Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatmentDavide Smussi0Carlo Conti1Luigi Lorini2Davide Mattavelli3Rosella Levaggi4Raffaele Miniaci5Stefano Calza6Alberto Deganello7Consiglia Paduano8Andrea Alberti9Salvatore Grisanti10Carla Ida Ripamonti11Alfredo Berruti12Cesare Piazza13Paolo Bossi14Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali CiviliUnit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali CiviliMedical Oncology and Hematology Unit, IRCCS Humanitas Research HospitalUnit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali CiviliDepartment of Economics and Management, University of BresciaDepartment of Economics and Management, University of BresciaBiostatistics, Department of Molecular and Translational Medicine, University of BresciaOtolaryngology Head and Neck Surgery Department, IRCCS National Cancer Institute (INT)Medical Oncology and Hematology Unit, IRCCS Humanitas Research HospitalMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali CiviliMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali CiviliDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of BresciaMedical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST-Spedali CiviliUnit of Otorhinolaryngology and Head and Neck Surgery, ASST-Spedali CiviliMedical Oncology and Hematology Unit, IRCCS Humanitas Research HospitalAbstract Background Financial toxicity from cancer treatments is rising as an important patient-reported outcome. Its relevance was first assessed in the context of privately financed healthcare system, where the financial hardship caused by out-of-pocket payments negatively affects survival, while fewer evidence exists on its role in countries where care is financed by the public health care system. Head and Neck Cancer (HNC) patients face an increased risk for financial toxicity due to multimodal treatment and relevant out of pocket costs. The aim of this study was to develop and validate an Italian version of the Canadian Financial Index of Toxicity (FIT) questionnaire, defined FITALY. Methods FIT questionnaire was translated through a forward-backward process by two investigators independently, and the process was reviewed by a certified medical scientific English native speaker. Once reached consensus upon Italian translation, two Health Economics experts were consulted to adapt the questionnaire to Italian socio-economic context. The FITALY questionnaire v1.0 hereby developed was anonymously administered to two consecutive groups of 30 patients who had received curative, multimodal treatment for HNC cancer at ASST Spedali Civili of Brescia, Italy. A cognitive debriefing form was simultaneously administered to ask patients to exclude recurring and redundant items and include new relevant items. Results The 14-item FITALY questionnaire provides a global evaluation of financial toxicity ranging from 0 to 100. The questionnaire is divided into 4 domains: financial burden (6 items), exploring the objective financial toxicity burden; financial distress (2 items), which refers to the psychological distress related to financial toxicity; out-of-pocket costs (4 items), which focus on medical expenses paid by the patient; and loss of productivity (2 items), that investigates the disease impact on both patient’s and caregiver’s job activity. Conclusions Starting from the Canadian 9-item FIT questionnaire, we developed and validated the Italian 14-item FITALY questionnaire. Prospective application to a cohort of Italian HNC patients is ongoing.https://doi.org/10.1186/s12885-024-13230-5Financial toxicityHead and neck cancerQuestionnaire development and validationSupportive carePatient financial burden |
| spellingShingle | Davide Smussi Carlo Conti Luigi Lorini Davide Mattavelli Rosella Levaggi Raffaele Miniaci Stefano Calza Alberto Deganello Consiglia Paduano Andrea Alberti Salvatore Grisanti Carla Ida Ripamonti Alfredo Berruti Cesare Piazza Paolo Bossi Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment BMC Cancer Financial toxicity Head and neck cancer Questionnaire development and validation Supportive care Patient financial burden |
| title | Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment |
| title_full | Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment |
| title_fullStr | Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment |
| title_full_unstemmed | Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment |
| title_short | Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment |
| title_sort | financial toxicity questionnaire fit development and validation of the italian version fitaly in head and neck cancer patients undergoing multimodal curative treatment |
| topic | Financial toxicity Head and neck cancer Questionnaire development and validation Supportive care Patient financial burden |
| url | https://doi.org/10.1186/s12885-024-13230-5 |
| work_keys_str_mv | AT davidesmussi financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT carloconti financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT luigilorini financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT davidemattavelli financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT rosellalevaggi financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT raffaeleminiaci financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT stefanocalza financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT albertodeganello financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT consigliapaduano financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT andreaalberti financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT salvatoregrisanti financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT carlaidaripamonti financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT alfredoberruti financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT cesarepiazza financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment AT paolobossi financialtoxicityquestionnairefitdevelopmentandvalidationoftheitalianversionfitalyinheadandneckcancerpatientsundergoingmultimodalcurativetreatment |